Add like
Add dislike
Add to saved papers

Laser-assisted in situ synthesis of graphene-based magnetic-responsive hybrids for multimodal imaging-guided chemo/photothermal synergistic therapy.

Talanta 2018 May 16
Magnetic graphene-based hybrids are being increasing recognized as an effective nanotheranostic agent in biomedicine. Conventional technologies for their synthesis have drawbacks not only from a synthetic standpoint, mainly requiring high temperatures and multi-step processes, but also from a biological perspective, chemical precursors or surfactants involved in the chemical process are toxic to cells. Herein, we report a novel approach for one-step fabricating magnetic graphene hybrid nanocomposites based on laser irradiation of an Fe target in GO-PEG aqueous solution at room temperature without using any other chemical reagent. TEM, XPS, FT-IR, XRD, Mossbauer spectrum and VSM observation reveal that γ-Fe2 O3 nanoparticles were directly grown on the surface of GO-PEG with uniform morphology and superior dispersibility. These GO-PEG-γ-Fe2 O3 nanocomposites (labeled as GPF) showed low cytotoxicity in vitro compared to chemically synthesized nanoparticles since the pulsed-laser-ablation-in-liquid (PLAL) process is free of toxic agents. After tail vein injection of the nanotheranostics, the tumor was clearly mapped by T2 -weighted magnetic resonance of γ-Fe2 O3 , photothermal imaging of graphene and fluorescence imaging of loaded antitumor DOX. Meanwhile the tumor cells both in vitro and in vivo achieved highly superior inhibition by the synergistic chemo/photothermal therapeutic effect which provided an intense heating effect and enhanced DOX release upon 808 nm NIR light exposure. The results revealed that the magnetic graphene-based hybrids prepared by PLAL is competent for future multi-modal imaging assisted tumor targeted chemo/photothermal synergistic therapy of cancer.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app